Driehaus Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-107,053
| Closed | -$4.11M | – | 464 |
|
2023
Q2 | $4.11M | Sell |
107,053
-648,283
| -86% | -$24.9M | 0.05% | 280 |
|
2023
Q1 | $17.5M | Sell |
755,336
-17,364
| -2% | -$402K | 0.25% | 139 |
|
2022
Q4 | $20.2M | Sell |
772,700
-108,984
| -12% | -$2.86M | 0.3% | 109 |
|
2022
Q3 | $17.3M | Buy |
881,684
+389,381
| +79% | +$7.66M | 0.26% | 117 |
|
2022
Q2 | $8.61M | Buy |
+492,303
| New | +$8.61M | 0.14% | 217 |
|